Litcius/Paper detail

The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival

Pasquale L. Fedele, Yang Liao, Jianan Gong, Yuan Yao, Mark F. van Delft, Michael Löw, Lin Tai, Marco J. Herold, Jacob T. Jackson, Charis E. Teh, Tania Tan, Lorraine A. O’Reilly, Julie Tellier, George Grigoriadis, David C.S. Huang, Wei Shi, Stephen L. Nutt, Simon N. Willis

2020Leukemia36 citationsDOI

Topics & Concepts

Transcription factorIRF4Multiple myelomaCancer researchBiologyOncologyMedicineGeneticsImmunologyGeneMultiple Myeloma Research and TreatmentsSignaling Pathways in DiseaseCancer Mechanisms and Therapy
The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival | Litcius